93270 ⎘
Derivatives of carbonic acid containing functional groups covered by groups - in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group Compounds containing any of the groups , e.g. aminoguanidine
Sub-classes:SELF-ASSEMBLED ACTIVE AGENTS
#2IGF2BP2 INHIBITORS AND USES THEREOF
#3Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof
#4SELF-ASSEMBLED ACTIVE AGENTS
#5THE TOTAL SYNTHESIS OF GLUCOSEPANE AND RELATED CHEMICAL REACTIONS, COMPOUNDS AND COMPOSITIONS AND OBTAINED THEREFROM AND METHODS OF TREATMENT
#6Gas generating agent, and method for producing foam using the same
#7Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
#8Therapeutic compounds
#9Inhibitors of creatine transport and uses thereof
#10Lipophilic guanidinium compounds for removal of oxyanions from aqueous solutions
#11Compounds and methods of treating infections
#12Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
#13Self-assembled active agents
#14Substituted glucosepanes and compositions thereof
#15GAS GENERATING AGENT, AND METHOD FOR PRODUCING FOAM USING THE SAME
#16Metal N-aminoguanidinate complexes for use in thin film fabrication and catalysis
#17Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
#18Inhibitors of creatine transport and uses thereof
#19Antiviral agent
#20Compounds and methods of treating infections
#21Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
#22Long chain base sphingosine kinase inhibitors
#23Method for measuring blood coagulation
#24Method of making ligand functionalized substrates
#25Method of making ligand functionalized substrates
#26Diterpenoid derivatives endowed of biological properties
#27Method of treating inflammation
#28Guanidine derivatives in cinnamic series
#29Aminoguanidinephenylphosphinate flame retardant compositions
#30Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#31Method for treating arthritis
#32BLOOD COAGULATION TIME PROLONGING AGENT
#33Method for producing biocidal polyguanidine, and biocidal polyguanidine
#34COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS
#35Method of making ligand functionalized substrates
#36Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
#37Use of Chk2 kinase inhibitors for cancer treatment
#38COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS
#39OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS
#40Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
#41Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
#42Process for the synthesis of high purity 3,5-diamino-6-(2,3-dichlorophenyl) (1,2,4-triazine)
#43Selective neuronal nitric oxide synthase inhibitors
#44Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells